| 000 | 01294 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511193453.0 | ||
| 264 | 0 | _c19920623 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0277-3732 | ||
| 024 | 7 |
_a10.1097/00000421-199206000-00015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeldman, E R | |
| 245 | 0 | 0 |
_aPhase II trial of recombinant tumor necrosis factor in disseminated malignant melanoma. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cJun 1992 |
||
| 300 |
_a256-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xtherapeutic use |
| 700 | 1 | _aCreagan, E T | |
| 700 | 1 | _aSchaid, D J | |
| 700 | 1 | _aAhmann, D L | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 15 _gno. 3 _gp. 256-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199206000-00015 _zAvailable from publisher's website |
| 999 |
_c1596763 _d1596763 |
||